Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Miles Meredith, M.D.,Ph.D.

Concepts

This page shows the publications David Meredith has written about Middle Aged.
Connection Strength

0.057
  1. Characterization of molecular signatures of supratentorial ependymomas. Mod Pathol. 2020 01; 33(1):47-56.
    View in: PubMed
    Score: 0.017
  2. Chondromyxoid Fibroma Arising in Craniofacial Sites: A Clinicopathologic Analysis of 25 Cases. Am J Surg Pathol. 2018 03; 42(3):392-400.
    View in: PubMed
    Score: 0.016
  3. IDH-mutant gliomas with additional class-defining molecular events. Mod Pathol. 2021 07; 34(7):1236-1244.
    View in: PubMed
    Score: 0.005
  4. Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile. Mod Pathol. 2021 02; 34(2):264-279.
    View in: PubMed
    Score: 0.005
  5. Molecular and clinicopathologic features of gliomas harboring NTRK fusions. Acta Neuropathol Commun. 2020 07 14; 8(1):107.
    View in: PubMed
    Score: 0.005
  6. Clinical Reasoning: A 58-year-old woman with loss of vision in her left eye. Neurology. 2016 Mar 08; 86(10):e101-7.
    View in: PubMed
    Score: 0.003
  7. An evaluation of low back pain among farmers in Ireland. Occup Med (Lond). 2013 Jan; 63(1):53-9.
    View in: PubMed
    Score: 0.003
  8. Human metabolic individuality in biomedical and pharmaceutical research. Nature. 2011 Aug 31; 477(7362):54-60.
    View in: PubMed
    Score: 0.003
  9. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum. 2002 Dec; 46(12):3349-60.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.